Search Results - "раково-специфическая выживаемость"

Relation: Жук, Е. Г. Роль магнитно-резонансной томографии в прогнозировании отдаленных результатов лечения рака шейки матки / Е. Г. Жук // Проблемы здоровья и экологии. – 2022. – Т. 19, № 3. – С. 58–64.; http://elib.gsmu.by/handle/GomSMU/12824

Availability: http://elib.gsmu.by/handle/GomSMU/12824

View record from BASE

4

Academic Journal

ORGAN-PRESERVING SURGERY FOR RENAL-CELL CARCINOMA ; ОРГАНОСОХРАНЯЮЩАЯ ХИРУРГИЯ ПОЧЕЧНО-КЛЕТОЧНОГО РАКА

Authors: A. S. Pereverzev, D. V. Shchukin, A. Yu. Shcherbak, А. С. Переверзев, Д. В. Щукин, А. Ю. Щербак

Source: Cancer Urology; Том 5, № 2 (2009); 22-30 ; Онкоурология; Том 5, № 2 (2009); 22-30 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2009-5-2

Subject Terms: раково-специфическая выживаемость, organ-preserving surgery, cancer-specific survival, органосохраняющие операции

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/263/280; Hollenberg B.K., Taub D.A., Miller D.C. et al. National utilization trends of partial nephrectomy for renal cell carcinoma: a case or underutilization? Urology 2006;(67):50—4.; Leibovich B.C., Blute M.L., Chevile J.C. et al. Nephron sparing surgery for appro- priately selective renal cell carcinoma between 4 and 7 sm results in outcome sim- ilar to radical nephrectomy. J Urol 2004;(17):1066—70.; Переверзев А.С. Органосохраняющие операции при опухолях почек и верхних мочевых путей. Урол респ сборн (Киев) 1985;(19):93—6.; Переверзев А.С. Хирургия опухолей почки и верхних мочевых путей. Харьков, 1987.; Huang W.C., Levey A.C., Serio A.M. et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumors: a retrospective cohort study. Lancet Oncol 2006;(7):735—40.; Becker F., Siemer S., Humke U. et al. Elective nephron sparing surgery should became standard treatment for small uni- lateral renal cell carcinoma: long-term sur- vival data of 216 patients. Eur Urol 2006;49:308—13.; Potard J.J., Crepel M., Pantuck A.J. et al. Morbidity and clinical outcome pf nephron sparing surgery in relation to tumor size and indication. Eur Urol 2006;(50):abstr 447.; Kleinmann N., Nadu A., Mor Y., Ramon G. Partial nephrectomy for central- ly located tumor. Eur Urol 2006;(50):abstr 633.; Ljungberg B., Hanbury D.C., Kuczun M.A. et al. European Association of Urology Guideline Group for renal cell carcinoma. Eur Urol 2007;(51):1502—10.; Переверзев А.С., Щукин Д.В., Илюхин Ю.В. Отдаленные результаты консервативного хирургического лечения почечноклеточного рака (ПКР). Урология 2001;(3):15—20.; Pereverzev A.C., Shukin D.V. Ergtnbnisse der konservativen Chirurgie von Nierenzellkarzinomen. J Urol Urogunakol 2001;(2):7—13.; Carini M., Minervini A., Masiieri G. et al. Simple enucleation for the treatment of pIa renal cell carcinoma. Eur Urol 2006;(50):1263—71.; Carini M., Minervini A., Serni S. et al. Nephron sparing surgery: current develop- ments and controversies. Eur Urol 2007;(51):12—4.; Terrone C., Cracco C., Poriglia F. et al. Reassessing the current TMN lymph node staging renal cell carcinoma. Eur Urol 2006;49:324—31.; Antonelly A., Cozzoli A., Nicolai M. et al. Nephron-sparing surgery versus radi- cal nephrectomy in the treatment of intra- capsular renal cell carcinoma up 7 sm. Eur Urol 2008;(53):803—9.; Campbell S.C., Novick A.C. Expanding the indication for elective par- tial nephrectomy: is this advisable? Eur Urol 2006;(49):952—4.; Lang H., Linder V., Martin M. Prognostic value of multifocality on pro- gression and survival in localized renal cell carcinoma. Eur Urol 2004;(45):749—53.; Shvarts O., Ajenozaffarder V., Kim H.J. et al. Nehpron-sparing surgery vs. the new gold standard for N1 7 cm results cell carcinoma,: results of contemporary UCLA series. J Urol 2004;171:74—80.; Roos F.S., Pahernick S., Brenner W. Elektive organerhaltende Nierentumor- Cherurgie bei Legenniere. Urologe 2008;(47):824—9.; Corini M., Minervini A., Lapini A. Simple enucleation for the treatment of greatest dimension: progression and long- term survival. J Urol 2006;157:2022—6.; Becker F., Siemer S., Roting J. et al. Organ erhaltnde Nierentumorchirurgie. Urologe 2008;(47):215—23.; Pahernik S., Roos F., Rohrin B. Elective nephron sparing for renal cell car- cinoma large than 4 cm. J Urol 2008;(179):71—9.; Joniau S., Van Poppel H. Nephron sparing surgery: experiens in 159 consecu- tive cases. Eur Urol 2006;(50):abstr 640.; Frank I., Blute M.G., Cheville J.C. et al. Solid renal tumors: an analysis of pathological feature related to tumor size. J Urol 2003;(170):2217.; Аляев Ю.Г., Крапивин А.А. Локализованный и местнораспространенный рак почки: нефрэктомия или резекция? Онкоурология 2005;(1):10—5.; Novic A.C., Campbell S.C. Renal tumor. Campbell’s Urology: Phyladelphia, 2002. p. 2672—731.; Van Poppel H., Deroo F., Joniau S. Open surgical treatment of localized renal cell cancer. EAU Update series 2003;(1):220—5.; Krejci K.G., Blute M., Chevile J.C. Nephron sparing surgery for renal cell car- cinoma: clinicopathologic feature patient outcame. Urologe 2003;(62):641—64.; Sengupta Sh., Zinke H., Leibovich B.C., Blute M.L. Surgical treatment of stage pT3b renal cell carcinoma in solitary kidney: a case series. Br J Urol Int 2005;96:54—7.; Boormans J., Marchand W., Usermans J. et al. «Bench» surgery with autotransplantation for hilar kidney tumors: a nephron sparing alternative in patients with solitary kidney. Eur Urol 2006, abstr 637.; Аляев Ю.Г., Григорян З.Г., Крапи- вин А.А. Тактика лечения при двустороннем раке почки. В сб.: Материалы конференции «Онкологическая урология: от научных исследований к клинической практике». М., 2004.; Uzzo R.G., Novic A.C. Nehpronsparing surgerion for renal tumor: indica- tions, techniques and outcomes. J Urol 2001;166:166—8.; Hruby G., Reisiger K., Venkatesh R. et al. Comparison of laparoscopic partial nephrectomy and laparoscopic cryoablation for renal hilar tumors. Urology 2006;(67):254—9.; Celia A., Albouy B., Lopes D et al. Laparoscopic partial nephrectomy: a multi- instutional Italian survey. Eur Urol 2006;(50):abstr 454; https://oncourology.abvpress.ru/oncur/article/view/263

Availability: https://oncourology.abvpress.ru/oncur/article/view/263
https://doi.org/10.17650/1726-9776-2009-5-2-22-30

View record from BASE

5

Academic Journal

PROGNOSTIC FACTORS OF SURVIVAL IN RENAL CANCER ; ФАКТОРЫ ПРОГНОЗА ВЫЖИВАЕМОСТИ ПРИ РАКЕ ПОЧКИ

Authors: A. V. Seriogin, O. B. Loran, V. R. Ashughyan, А. В. Серегин, О. Б. Лоран, В. Р. Ашугян

Source: Cancer Urology; Том 5, № 2 (2009); 15-21 ; Онкоурология; Том 5, № 2 (2009); 15-21 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2009-5-2

Subject Terms: факторы прогноза, cancer-specific survival rate, prognosis factors, раково-специфическая выживаемость

File Description: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/216/233; Клиническая онкоурология. Под ред. проф. Б.П. Матвеева. М.: Вердана, 2003.; Whelan P. The medical treatment of metastatic renal cell cancer. EAU Update Series 2003;1:237—46.; Figlin RA. Renal cell carcinoma: man- agement of advanced disease. J Urol 1999;161:381—7.; Available at URL: http://www.seer.can- cer.gov/; Lam J.S., Shvarts O., Leppert J.T. et al. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005;173: 1853—62.; Karakiewicz P.I., Lewinshtein D.J., Chun F.K.-H. et al. Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol 2006;50:521—9.; Sobin L.H. TNM classification of malignant tumours. Ed. 6. New York: Wiley-Liss, 2002. p. 193—5.; Fuhrman S.A., Lasky L.C., Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655—63.; Lang H., Lindner V., de Fromont M. et al. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: assessment of 241 patients with >15-year follow-up. Cancer 2005;103:625—9.; Kim H.L., Belldegrun A.S., Freitas D.G. et al. Paraneoplastic signs and symptoms of renal cell carcinoma: implica- tions for prognosis. J Urol 2003;170: 1742—6.; Patard J.J., Leray E., Cindolo L. et al. Multi-institutional validation of a symp- tom-based classification for renal cell car- cinoma. J Urol 2004;172:858—62.; Kattan M.W., Reuter V., Motzer R.J. et al. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001;166:63—7.; Frank I., Blute M.L., Cheville J.C. et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002;168:2395—400.; Zisman A., Pantuck A.J., Wieder J. et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002;20:4559—66.; Martignoni G., Brunelli M., Gobbo S. et al. Role of molecular markers in diagno- sis and prognosis of renal cell carcinoma. Anal Quant Cytol Histol 2007;29:41—9.; Patard J.-J., Rioux-Leclercq N., Fergelot P. Understanding the importance of smart drugs in renal cell carcinoma. Eur Urol 2006;49:633—43.; Patard J.-J. With increasing minimally invasive options for small renal tumours, it is time to develop patient-specific treat- ment strategies. Eur Urol 2007;51: 876—8.; Siddiqui S.A., Frank I., Leibovich B.C. et al. Impact of tumor size on the predictive ability of the pT3a primary tumor classifi- cation for renal cell carcinoma. J Urol 2007;177(1):59—62.; Karakiewicz P.I., Lewinshtein D.J., Chun F.K.-H. et al. Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol 2006;5(3):5; —9. 20. Karakiewicz P.I., Trinh Q.-D., Bhojani N. et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol 2007;51(6):1616—24. 21. Patard J., Rodriguez A., Rioux-Leclercq N. et al. Prognostic signifi- cance of the mode of detection in renal tumours. BJU Int 2002;90(4):358—63.; Erdemir F., Kilciler M., Bedir S. et al. Clinical significance of platelet count in patients with renal cell carcinoma. Urol Int 2007;79(2):111—6.; Bensalah K., Leray E., Fergelot P. et al. Prognostic value of thrombocytosis in renal cell carcinoma. J Urol 2006;175(3 Pt 1):859—63.; https://oncourology.abvpress.ru/oncur/article/view/216

Availability: https://oncourology.abvpress.ru/oncur/article/view/216
https://doi.org/10.17650/1726-9776-2009-5-2-15-21

View record from BASE

6

Academic Journal